Scientific Data and Presentations

Company announcements:

Press Release: Study shows that altering insemination timing can improve a couple’s ability to conceive, either naturally or through assisted reproduction.
Published Manuscript: G. Charles Ostermeier, Cristina Cardona, Melissa A. Moody, Alana J. Simpson, Romeo Mendoza, Eric Seaman, Alexander J. Travis. Timing of sperm capacitation varies reproducibly among men (2018). Mol. Reprod Dev. 2018; 1-10.

Press Release: Study projects the clinical impact of the Cap-Score™ by improving pregnancy rates and saving couples time and money.
Published Manuscript: Babigumira, J.B., Sharara, F.I. & Garrison, L.P. Projecting the potential impact of the Cap-Score™ on clinical pregnancy, live births, and medical costs in couples with unexplained infertility. J Assist Reprod Genet (2017).

Press Release: Studies validate the clinical utility of the Cap-Score™.
Published Manuscript: Cardona CNeri QVSimpson AJ, et al. Localization patterns of the ganglioside GM1 in human sperm are indicative of male fertility and independent of traditional semen measuresMol Reprod Dev201784:423435.
Published Manuscript: Moody MACardona CSimpson AJSmith TTTravis AJOstermeier GCValidation of a laboratory-developed test of human sperm capacitationMol Reprod Dev201784:408422.

Androvia LifeSciences will have a presence at the following scientific meetings in 2018:

ASRM: American Society of Reproductive Medicine
October 6-10, 2018; Denver, Colorado
Booth # 1124

AUA: American Urological Assocation
May 18-21, 2018; San Francisco, CA
Booth # 6075

SSMR: Society for the Study of Male Reproduction
May 20, 2018; San Francisco, CA

ASA: American Society for Andrology
April 21-24, 2018; Portland, OR
Multiple abstracts accepted for poster presentations

Data presented at past scientific meetings:

ASA: American Society of Andrology
April 22-25, 2017; Miami, FL
Exhibited and presented one study.

  • Abstract #P-136Localization patterns of the ganglioside GM1 identify sperm capable of undergoing capacitation and acrosome exocytosis
    Poster session: Monday, April 24th @ 11:15am-12:30pm

ASRM: American Society of Reproductive Medicine
October 15-19, 2016; Salt Lake City, UT
Booth # 323 and presented two studies.

  • Abstract #P-354: Capacitation defects are common in men questioning their fertility and are independent of standard semen analysis parameters
    Poster Session: Tuesday, October 18th @ 7:00am-8:45am
  • Abstract #P-523: Capacitation timing varies among men, but is consistent among ejaculates within individuals
    Poster Session: Wednesday, October 19th @ 7:00am-8:45am

AUA: American Urological Association + SSMR Annual Meeting: Society for the Study of Male Reproduction
May 6-10, 2016; San Diego, CA
Booth # 4152 and presented one study.

  • Abstract #MP70-10: Impacts of common semen handling methods on sperm function
    Poster Session: Monday, May 9th @ 10:30am-12:30pm

ASA: American Society of Andrology
April 2-5, 2016; New Orleans, LA
Exhibited and presented four studies.

  • Abstract #12: Consistent differences among men in capacitation timing could personalize IUI/ART
    Oral Presentation: Sunday, April 3rd @ 3:15pm
    Poster Session: Sunday, April 3rd @ 11:00am-12:30pm
  • Abstract #138: Normal ejaculates, as defined by WHO, can have abnormal capacitation ability
    Poster Session: Monday, April 4th @ 11:15am-12:30pm
  • Abstract #140: Sperm from fertile men and those seeking fertility exams differ in their ability to capacitate
    Poster Session: Monday, April 4th @ 11:15am-12:30pm
  • Abstract #137: Reliability estimates for a test of sperm capacitation, a functional complement to semen analysis
    Poster Session: Monday, April 4th @ 11:15am-12:30pm

# # #

A New Test for Male Infertility is on the Horizon: The Androvia Cap-Score

Male Fertility Doc, January 27, 2016
Coming soon, a company named Androvia will be releasing a new test that assesses the fertilizing ability of a man’s sperm.  Prior to fertilization, an individual sperm must complete three tasks: “capacitation”, “hyperactivation” and the “acrosome reaction”.  Androvia uses technology that identifies the ability of sperm to undergo capacitation.